Genentech, Inc.South San Francisco, CA, United States (NYSE: DNA)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Genentech Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Quarter
Ending Jun 08
Quarter
Ending Mar 08
Quarter
Ending Dec 07
Quarter
Ending Sep 07
Quarter
Ending Jun 07
Revenue 3,236.0 3,063.0 2,969.0 2,908.0 3,004.0
Cost of Goods Sold 442.0 389.0 344.0 406.0 429.0
Gross Profit 2,794.0 2,674.0 2,625.0 2,502.0 2,575.0
Gross Profit Margin 86.3% 87.3% 88.4% 86.0% 85.7%
SG&A Expense 1,419.0 1,016.0 1,493.0 1,311.0 1,342.0
Depreciation & Amortization 146.0 139.0 147.0 130.0 109.0
Operating Income 1,229.0 1,519.0 985.0 1,061.0 1,124.0
Operating Margin 38.0% 49.6% 33.2% 36.5% 37.4%
Nonoperating Income 92.0 74.0 40.0 84.0 75.0
Nonoperating Expenses 14.0 18.0 23.0 18.0 17.0
Income Before Taxes 1,307.0 1,575.0 1,002.0 1,127.0 1,182.0
Income Taxes 526.0 592.0 371.0 442.0 435.0
Net Income After Taxes 781.0 983.0 631.0 685.0 747.0

Continuing Operations 781.0 983.0 631.0 685.0 747.0
Discontinued Operations -- -- -- -- --
Total Operations 781.0 983.0 631.0 685.0 747.0
Total Net Income 781.0 983.0 631.0 685.0 747.0
Net Profit Margin 24.1% 32.1% 21.3% 23.6% 24.9%

Diluted EPS from Total Net Income ($) 0.73 0.92 0.59 0.64 0.70
Dividends per Share -- -- -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online